Dr. Eugene Ryan, MD

NPI: 1609865088
Total Payments
$78,046
2024 Payments
$1,884
Companies
49
Transactions
434
Medicare Patients
4,578
Medicare Billing
$438,773

Payment Breakdown by Category

Other$33,863 (43.4%)
Consulting$15,601 (20.0%)
Research$10,240 (13.1%)
Travel$9,622 (12.3%)
Food & Beverage$8,715 (11.2%)
Education$6.02 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $33,863 20 43.4%
Consulting Fee $15,601 6 20.0%
Unspecified $10,240 20 13.1%
Travel and Lodging $9,622 49 12.3%
Food and Beverage $8,715 338 11.2%
Education $6.02 1 0.0%

Payments by Type

General
$67,806
414 transactions
Research
$10,240
20 transactions

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $28,265 69 $0 (2023)
Novo Nordisk Inc $15,164 90 $0 (2024)
GlaxoSmithKline, LLC. $14,815 42 $0 (2021)
Eli Lilly and Company $9,706 9 $0 (2019)
AstraZeneca Pharmaceuticals LP $2,268 42 $0 (2024)
Novo Nordisk AS $1,506 4 $0 (2017)
Boehringer Ingelheim International GmbH $1,459 12 $0 (2023)
Kowa Research Institute, Inc. $1,152 11 $0 (2017)
Chiesi USA, Inc. $772.01 2 $0 (2023)
Amgen Inc. $498.73 30 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,884 21 AstraZeneca Pharmaceuticals LP ($1,740)
2023 $3,159 46 Boehringer Ingelheim International GmbH ($1,459)
2022 $887.72 37 Novo Nordisk Inc ($170.69)
2021 $1,997 27 Novo Nordisk Inc ($1,721)
2020 $9,936 29 Novo Nordisk Inc ($7,539)
2019 $11,654 73 Novo Nordisk Inc ($5,256)
2018 $17,415 84 Eli Lilly and Company ($6,141)
2017 $31,113 117 Janssen Pharmaceuticals, Inc ($21,364)

All Payment Transactions

434 individual payment records from CMS Open Payments — Page 1 of 18

Date Company Product Nature Form Amount Type
10/24/2024 AstraZeneca Pharmaceuticals LP Travel and Lodging In-kind items and services $560.88 General
10/24/2024 AstraZeneca Pharmaceuticals LP Travel and Lodging In-kind items and services $261.06 General
10/24/2024 AstraZeneca Pharmaceuticals LP Travel and Lodging In-kind items and services $261.06 General
10/24/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $135.00 General
10/24/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $125.00 General
10/24/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $50.00 General
10/24/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $50.00 General
10/24/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $50.00 General
10/24/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $50.00 General
10/24/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $15.00 General
10/24/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $15.00 General
10/24/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $15.00 General
10/24/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $15.00 General
06/25/2024 INTUITIVE SURGICAL, INC. Da Vinci Surgical System (Device) Food and Beverage In-kind items and services $24.74 General
Category: SURGERY
06/14/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $48.41 General
03/21/2024 Esperion Therapeutics, Inc. NEXLETOL (Drug) Food and Beverage In-kind items and services $18.50 General
Category: ANTILIPEMIC AGENTS
03/19/2024 PFIZER INC. PREVNAR 20 (Biological), COMIRNATY, ABRYSVO Food and Beverage In-kind items and services $20.36 General
Category: VACCINES
03/12/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $18.05 General
02/19/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $126.14 General
01/24/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $11.04 General
Category: Respiratory
01/09/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $13.77 General
Category: Diabetes
11/27/2023 Xeris Pharmaceuticals, Inc. GVOKE HYPOPEN (Drug) Food and Beverage In-kind items and services $19.00 General
Category: Diabetes
11/22/2023 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $24.42 General
Category: Diabetes Care
11/22/2023 PFIZER INC. PREVNAR 20 (Biological), COMIRNATY, ABRYSVO Food and Beverage In-kind items and services $21.97 General
Category: VACCINES
11/15/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $19.21 General
Category: Diabetes

Research Studies & Clinical Trials

Study Name Company Amount Records
A RANDOMIZED, DOUBLE-BLIND, PARALLEL ARM STUDY OF THE EFFICACY AND SAFETY OF INVESTIGATIONAL DULAGLUTIDE DOSES WHEN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS Eli Lilly and Company $8,366 4
A Clinical Outcomes Study to compare the effect of Fluticasone Furoate Vilanterol Inhalation Powder 100 25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease COPD and a history of or at increased risk for cardiov GlaxoSmithKline, LLC. $725.82 6
A PHASE III, 52 WEEK, RANDOMIZED, DOUBLE BLIND, 3-ARM PARALLEL GROUP S GlaxoSmithKline, LLC. $705.62 9

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 16 1,072 1,551 $321,735 $103,881
2022 17 1,133 1,654 $329,520 $114,232
2021 23 1,234 1,820 $361,577 $123,731
2020 17 1,139 1,578 $317,705 $96,928
Total Patients
4,578
Total Services
6,603
Medicare Billing
$438,773
Procedure Codes
73

All Medicare Procedures & Services

73 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 289 536 $105,592 $40,675 38.5%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 242 242 $75,504 $29,539 39.1%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 87 133 $47,570 $7,977 16.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 81 98 $13,034 $5,786 44.4%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 45 59 $31,398 $5,327 17.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 39 41 $10,865 $5,212 48.0%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2023 35 35 $6,405 $2,653 41.4%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 12 12 $5,136 $1,879 36.6%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 20 20 $11,048 $1,731 15.7%
G0008 Administration of influenza virus vaccine Office 2023 40 40 $2,680 $1,138 42.4%
71046 X-ray of chest, 2 views Office 2023 55 58 $4,930 $882.25 17.9%
96372 Injection of drug or substance under skin or into muscle Office 2023 38 89 $5,963 $793.38 13.3%
J1040 Injection, methylprednisolone acetate, 80 mg Office 2023 20 20 $500.00 $156.02 31.2%
81003 Automated urinalysis test Office 2023 31 50 $500.00 $110.00 22.0%
J0696 Injection, ceftriaxone sodium, per 250 mg Office 2023 18 41 $533.00 $16.46 3.1%
J1100 Injection, dexamethasone sodium phosphate, 1 mg Office 2023 20 77 $77.00 $6.33 8.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 301 588 $115,836 $46,794 40.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 231 231 $72,072 $28,734 39.9%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 147 234 $78,858 $18,104 23.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 77 91 $12,103 $4,801 39.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 30 35 $9,275 $4,240 45.7%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2022 50 51 $9,333 $3,567 38.2%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 28 28 $9,184 $2,205 24.0%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2022 12 12 $5,136 $1,895 36.9%
G0008 Administration of influenza virus vaccine Office 2022 53 54 $3,618 $1,468 40.6%

About Dr. Eugene Ryan, MD

Dr. Eugene Ryan, MD is a Internal Medicine healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609865088.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eugene Ryan, MD has received a total of $78,046 in payments from pharmaceutical and medical device companies, with $1,884 received in 2024. These payments were reported across 434 transactions from 49 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($33,863).

As a Medicare-enrolled provider, Ryan has provided services to 4,578 Medicare beneficiaries, totaling 6,603 services with total Medicare billing of $438,773. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Chattanooga, TN
  • Active Since 10/18/2005
  • Last Updated 02/10/2022
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1609865088

Products in Payments

  • INVOKANA (Drug) $28,163
  • TRULICITY (Drug) $9,742
  • RYBELSUS (Drug) $5,324
  • Ozempic (Drug) $4,550
  • Victoza (Drug) $4,094
  • TRELEGY ELLIPTA (Drug) $2,190
  • Tresiba (Drug) $1,593
  • FARXIGA (Drug) $319.24
  • SOLIQUA (Drug) $183.94
  • TOUJEO (Drug) $168.19
  • Repatha (Biological) $153.04
  • NEXLETOL (Drug) $150.35
  • Kerendia (Drug) $146.99
  • EVENITY (Biological) $143.15
  • PREVNAR 20 (Biological) $104.86
  • Aimovig (Biological) $99.71
  • Prolia (Biological) $80.03
  • JARDIANCE (Drug) $71.25
  • Rybelsus (Drug) $70.49
  • ACTHAR (Biological) $68.49

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Chattanooga